Clinical Trial Detail

NCT ID NCT03344536
Title A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer
Recruitment Recruiting
Gender female
Phase
Variant Requirements yes
Sponsors
Indications

Her2-receptor negative breast cancer

Therapies

Debio 1347 + Fulvestrant

Age Groups: senior adult

Additional content available in CKB BOOST